ライフサイエンスコーパス: muscle strength

1 o effect on serum creatine kinase levels and muscle strength.

2 core for the ICU scores with improvements in muscle strength.

3 yneuropathy (DPN) is associated with loss of muscle strength.

4 nerve conduction velocities and ameliorated muscle strength.

5 rength, and diaphragm function and increased muscle strength.

6 arked by decreased lifespan, body weight and muscle strength.

7 d serum creatine kinase levels, or decreased muscle strength.

8 of the adequacy of recovery of postoperative muscle strength.

9 y nutrition supplementation on adult LBM and muscle strength.

10 ad a positive association with adult LBM and muscle strength.

11 other skeletal muscle diseases with loss of muscle strength.

12 (daily TV viewing time and internet use) and muscle strength.

13 stretching and resistance exercises improved muscle strength.

14 m (SR), but came at the expense of decreased muscle strength.

15 cterized by myofiber atrophy and the loss of muscle strength.

16 and improved pole balance, but no change in muscle strength.

17 cular atrophy associated with a reduction in muscle strength.

18 ber and severity of lymphedema symptoms, and muscle strength.

19 rated below normative values for VO2peak and muscle strength.

20 agnetic resonance imaging, and knee extensor muscle strength.

21 ment in muscle strength or maintained normal muscle strength.

22 es lean body mass, bone mineral content, and muscle strength.

23 ol subjects between genotype and inspiratory muscle strength.

24 nscriptome changes strongly correlating with muscle strength.

25 scued the deficits in oxidative capacity and muscle strength.

26 um plantarflexion torque, indicating reduced muscle strength.

27 keletal muscle to reduce atrophy and improve muscle strength.

28 red, along with test results for fitness and muscle strength.

29 ranscript reading frame, and thereby enhance muscle strength.

30 milarly hinders regeneration and compromises muscle strength.

31 lure, with specific attention to respiratory muscle strength.

32 ype IIb fiber hypertrophy, and ultimately in muscle strength.

33 acteristics, including a low muscle mass and muscle strength.

34 complexity and function resulting in reduced muscle strength.

35 zyme function, which are likely to influence muscle strength.

36 th the ALSFRS-R (0.43 (0.39-0.46), p<0.001), muscle strength (0.55 (0.51-0.58), p<0.001) and overall

37 ygen consumption per unit time [$$ VO2], and muscle strength (1-repetition maximum strength).

38 Only stretching and resistance improved muscle strength (16% increase; P<.001).

39 eg LTM (0.22 kg; 95% CI: 0.02, 0.42 kg), and muscle strength (18%; 95% CI: 0.03, 0.34) than did the C

40 h (64%), provide more energy (31%), increase muscle strength (25%), and enhance performance (17%).

41 -sectional area (3.7% to 4.9%), leg and back muscle strength (26% to 40%), and executive function (z-

42 ngth (2.3 kg; 95% CI: 0.8, 3.7 kg), and 1-RM muscle strength (4.0%; 95% CI: 0.8%, 7.3%) (all P < 0.05

43 study of 6- and 12-month physical outcomes (muscle strength, 6-minute-walk distance, and Short Form

44 om were detected a median of 2.4 days and in muscle strength a median of 4.8 days after HBAT.

45 d on manual and quantitative measurements of muscle strength, a disease-modifying effect of creatine

46 Muscle strength adjusted for age, sex, and BMI was lower

47 y adaptations in genes associated with diet, muscle strength, agility, and other traits responsible f

48 X) in ACTN3 results in significantly reduced muscle strength and a longer 10 m walk test time in youn

49 pproximately 25% of animals, but with normal muscle strength and a normal lifespan.

50 ed that concentric/isometric strain improved muscle strength and alleviated muscular dystrophy by lim

51 d with significant impressive improvement in muscle strength and amelioration of fibrosis.

52 esults also show the importance of improving muscle strength and area and lowering muscle adipose tis

53 uce a reproducible increase in both skeletal muscle strength and cardiac contractile performance that

54 survivors that is characterized by impaired muscle strength and causes functional disability.

55 Before and after immobilization, muscle strength and compartmental tissue composition wer

56 trate that Dox treatment of P30 mice reduced muscle strength and compound muscle action potentials.

57 Myosin is the primary regulator of muscle strength and contractility.

58 igated whether a linear relationship between muscle strength and cross-sectional area (CSA) is preser

59 ylline demonstrated improved AROM, PROM, and muscle strength and decreased limb edema and pain.

60 Compared to WT, muscle strength and depolarization-induced calcium trans

61 uation of cachexia with preserved whole body muscle strength and endurance capacity in the absence of

62 l and eugonadal patients had equivalent limb muscle strength and endurance.

63 ophy; however, there were no improvements in muscle strength and exacerbation of exercise intolerance

64 nown about the effect of statins on skeletal muscle strength and exercise performance.

65 fficient data to determine if statins affect muscle strength and exercise performance.

66 An edrophonium test revealed improvement in muscle strength and eyelid ptosis.

67 Muscle strength and function correlated directly with se

68 Muscle strength and function improved over time without

69 he clinical history, laboratory findings and muscle strength and function in 57 patients with genetic

70 the past year and includes methods to assess muscle strength and function in children with myositis.

71 eter, resulting in long-term improvements in muscle strength and function in mdx mice.

72 condary outcome measures of creatine kinase, muscle strength and function, motor nerve conduction, ac

73 ultifidus: timed up and go) as well as trunk muscle strength and functional ability (trunk composite

74 Muscle strength and functional capacity were assessed be

75 rength training on the neuromuscular system (muscle strength and functional capacity) of older women.

76 pplementation caused greater improvements in muscle strength and functional capacity.

77 A decrease in skeletal muscle strength and functional exercise capacity due to

78 Muscle strength and functional mobility were also measur

79 Secondary endpoints were urinary continence, muscle strength and functional status, the need for cort

80 Older men and women with weak muscle strength and high BMI have considerably poorer pe

81 evere motor abnormalities, major deficits in muscle strength and histopathological changes in muscle.

82 ceptor (beta(2)AR) agonist enhances skeletal muscle strength and hypertrophy; however, its clinical u

83 As in mammals, ethanol exposure impairs muscle strength and induces the expression of protective

84 deteriorates, while its inhibitor improves, muscle strength and insulin sensitivity in osteoporotic

85 rgement of NMJs and substantial increases in muscle strength and life span.

86 e adequate performance in tasks that reflect muscle strength and locomotion.

87 of ER stress, significantly reduced skeletal muscle strength and mass in both control and LLC-bearing

88 and exogenous trophic factors on extraocular muscle strength and mass were examined in the developing

89 analysis was used to examine trajectories of muscle strength and mobility across time by sex as condi

90 ion of metabolic genes and induced a loss of muscle strength and morphological deterioration of the m

91 dictive for the patient's functional status, muscle strength and mortality risk.

92 recovery after cerebral ischemia, as well as muscle strength and motor function.

93 aily salbutamol injection, and the effect on muscle strength and neuromuscular junction morphology wa

94 x studies examining the effect of statins on muscle strength and nine studies examining their effect

95 Age-related sarcopenia describes the loss of muscle strength and often accompanies an increase in adi

96 Resistance training (RT) improves muscle strength and overall physical function in older a

97 ssessing: physiological determinants of peak muscle strength and oxidative capacity and muscle biopsy

98 l tibial muscle compartment of GRMD dogs and muscle strength and pathology were assessed.

99 dy composition (including reducing IMAT) and muscle strength and physical function in obese elderly,

100 Deficits in quadriceps muscle strength and physical performance are common in L

101 ietary intakes of antioxidants with skeletal muscle strength and physical performance in elderly pers

102 Muscle strength and physical performance in old age migh

103 ndividuals who have had recent falls and low muscle strength and power.

104 This leads to increase in muscle strength and prevents cardiac pump failure induce

105 with impaired versus nonimpaired measures of muscle strength and pulmonary function had significantly

106 fiber regeneration and repair with improved muscle strength and reduced muscle fibrosis in the GRMD

107 Targeted deletion of TRAF6 improves muscle strength and reduces fiber necrosis, infiltration

108 for enhancing the effects of PRT on LTM and muscle strength and reducing circulating IL-6 concentrat

109 n situ protocols in the mdx mouse to measure muscle strength and resistance to eccentric contraction-

110 week (every third day) that maintained whole muscle strength and size.

111 nal associations between functional decline, muscle strength and survival with plasma creatinine were

112 is reflected in loss of range of motion and muscle strength and the development of limb edema and pa

113 re the time to achieve >/=20% improvement in muscle strength and the proportions of patients in the e

114 ciation of sarcopenic obesity and changes in muscle strength and weight with the risk of mortality.Pa

115 in 1 second was also associated with weaker muscle strength and with a greater risk of self-reported

116 with glucose dysregulation, lower levels of muscle strength, and a heightened risk of disability.

117 Magnetic resonance imaging (MRI), muscle strength, and blood parameters were used as outco

118 esting included assessment of CRF (VO2peak), muscle strength, and body composition (%fat).

119 ent mice prevents muscle pathology, improves muscle strength, and dramatically increases life expecta

120 ements in total body and leg lean mass (LM), muscle strength, and executive function (multiple primar

121 Therefore, exercise can improve gait speed, muscle strength, and fitness for patients with Parkinson

122 improved exercise capacity, lower extremity muscle strength, and health-related quality of life.

123 se ALS, the drug delayed loss of neurons and muscle strength, and increased mouse survival.

124 ciated with glucose dysregulation, decreased muscle strength, and increased risk of disability.

125 unction, body composition, aerobic capacity, muscle strength, and inflammatory/antiinflammatory bioma

126 atus, level of activity, respiratory status, muscle strength, and mobility at ICU discharge.

127 with objective measures of aerobic fitness, muscle strength, and muscle endurance, using data on 31-

128 ation of their joint structure and function, muscle strength, and neuromuscular function, and people

129 esting energy expenditure, cardiac function, muscle strength, and number of reconstructive procedures

130 x recipients have significantly reduced CRF, muscle strength, and physical activity.

131 included demographic information, quadriceps muscle strength, and QA using a burst-superimposition is

132 ized APA and its impact on aerobic capacity, muscle strength, and quality of life before LT.

133 availability, safety, bone turnover markers, muscle strength, and quality of life.

134 ody composition, resting energy expenditure, muscle strength, and serum human growth hormone, insulin

135 stay, physical function and quality of life, muscle strength, and ventilator-free days were included.

136 ung function, exercise capacity, respiratory muscle strength, and ventilatory efficiency.

137 pervised or home-based) on body composition, muscle strength, and walking capacity of liver transplan

138 ents, exercise is able to improve lean mass, muscle strength, and, as a consequence, aerobic capacity

139 ons of extremity, hand grip, and respiratory muscle strength; anthropometrics (height, weight, mid-ar

140 y 35% of children had diminished respiratory muscle strength (aPiMax </= 30 cm H2O) at the time of ex

141 ia is defined, both low muscle mass and poor muscle strength are clearly highly prevalent and importa

142 Strikingly, we show that changes in muscle strength are proportional to dystrophin expressio

143 lower limbs (medical research council graded muscle strength as 4+ out of 5) that was associated with

144 (-0.30 kg/kg) from baseline in weight-scaled muscle strength as indicated by QMA, and the dutasteride

145 d histological muscle pathology and improved muscle strength as well as exercise performance.

146 orrelates with reduced fibrosis and improved muscle strength as well as reduced natural killer T (NKT

147 atment resulted in a significant increase in muscle strength, as determined by generation of specific

148 Each respiratory muscle strength assessment individually achieved statist

149 e, setting and method, and equipment of limb muscle strength assessment) and reliability scores were

150 ere obtained on reliability of nonvolitional muscle strength assessment.

151 ower of invasive and noninvasive respiratory muscle strength assessments for survival or ventilator-f

152 ncreases in IMAT may contribute to losses in muscle strength associated with reduced physical activit

153 Two patients maintained their increased muscle strength at 52 weeks, and 1 of these patients mai

154 ilitary conscripts, low aerobic capacity and muscle strength at age 18 years were associated with inc

155 Muscle strength at the knee and ankle was determined wit

156 ured creatine kinase, exercise capacity, and muscle strength before and after atorvastatin 80 mg or p

157 ockout mouse model, which also shows reduced muscle strength, but is protected from stretch-induced e

158 als is independently associated with greater muscle strength, but not with the mobility score, in old

159 ctivator, CK-2017357, as a means to increase muscle strength by amplifying the response of muscle whe

160 come measures included hindlimb and forelimb muscle strength by Grip Strength Meter and quantitative

161 ral magnesium supplementation on respiratory muscle strength by using manuvacuometry and the Shwachma

162 ved lean body mass, bone mineral content and muscle strength compared with controls during treatment,

163 tes lead to a catabolic state with decreased muscle strength, contributing to disease-related morbidi

164 stantial improvements on behavioral tests of muscle strength, coordination, and locomotion, indicatin

165 pacity (6-min walk distance), and quadriceps muscle strength corrected for body weight (QS%).

166 Muscle strength/CSA relationships were significantly low

167 ht, body mass index (BMI), body composition, muscle strength, cytokines, complications, and QL.

168 sical performance deteriorated over 3 y with muscle strength declining more than the mobility score i

169 Thigh muscle strength does not appear to predict incident radi

170 The progressive loss of muscle strength during aging is a common degenerative ev

171 More importantly, reduced muscle strength during critical illness is an independen

172 ith reduced ejection fraction and HC reduced muscle strength (eccentric extension: 13.3+/-5.0 versus

173 uscle weight, functionality (grooming tests, muscle strength), electrophysiology and histomorphology

174 ticity at the neuromuscular junction and for muscle strength, endurance, and motor coordination in mi

175 confidence interval 0.13, 0.78), peripheral muscle strength (g = 0.27, 95% confidence interval 0.02,

176 idence interval 0.02, 0.52), and respiratory muscle strength (g = 0.51, 95% confidence interval 0.12,

177 y and sixteen showed clear benefit of MOD on muscle strength gains.

178 e the effects of exercise on any measures of muscle strength, gait speed, dynamic balance, reaction t

179 sures were standardized measures of skeletal muscle strength, gait, balance, quality of life, and bod

180 the following 2 functional composite scores: muscle strength (handgrip, arm, and leg) and mobility (t

181 f joint or muscle innervation, or inadequate muscle strength have increased risk of joint damage duri

182 ouped by sex (men, n = 9; women, n = 12) and muscle strength (higher strength, n = 7; moderate streng

183 eg resistance training led to: (i) increased muscle strength; (ii) myofibre damage and regeneration;

184 In non-treated cases, disease severity and muscle strength improved gradually over time and several

185 cts on atorvastatin or placebo had decreased muscle strength in 5 of 14 and 4 of 14 variables, respec

186 utrition with adult lean body mass (LBM) and muscle strength in a birth cohort that was established t

187 (ATA 842) for 4 wk increased muscle mass and muscle strength in both groups.

188 in the VDR gene are associated with skeletal muscle strength in both patients and control subjects, w

189 salbutamol leads to a gradual improvement in muscle strength in ColQ-/- mice.

190 Strength training increased muscle strength in elderly women.

191 asing AMPD1 expression resulted in decreased muscle strength in healthy mice.

192 s on MRI, which correlated well with reduced muscle strength in hip and knee flexors and extensors.

193 Provocation reduced muscle strength in HyperPP (before provocation, median M

194 OPG also improves muscle strength in mouse models of Duchenne's muscular d

195 signaling increases muscle mass and improves muscle strength in mouse models of primary muscle diseas

196 might be a therapeutic mechanism to increase muscle strength in nebulin deficient muscle.

197 gestive evidence that these drugs may reduce muscle strength in older patients and alter energy metab

198 escribes strategies to control perioperative muscle strength in patients undergoing ambulatory surger

199 ed improve both the SK score and respiratory muscle strength in pediatric patients with CF.

200 e innervation, muscle matrix remodeling, and muscle strength in response to exercise training.

201 ver time and several adults recovered normal muscle strength in the limbs.

202 nificant morbidity associated with decreased muscle strength in the older kidney transplant populatio

203 interventions to reduce fat mass and improve muscle strength in the prevention of future functional l

204 uction in endurance and 1.6-fold decrease in muscle strength in these mice.

205 easurements, that physical therapy increases muscle strength in this population.

206 inimum Feret diameter, p < 0.001), increased muscle strength in vitro (p < 0.001) and in vivo (p = 0.

207 ovide a more biological method of decreasing muscle strength in vivo than exogenously administered to

208 eased muscle action potential amplitudes and muscle strengths in the range of wild-type mice.

209 Plantar flexor muscle strength increased in chronic stroke patients aft

210 It improved muscle strength, increased time-to-fatigue (for VO(2max)

211 s exhibited major clinical improvement, with muscle strength increasing over baseline by 36-113%.

212 hysical function, peripheral and respiratory muscle strength, increasing ventilator-free days, and de

213 rect correlation of testosterone levels with muscle strength indicates that androgens may have a posi

214 xins, a more biological approach to decrease muscle strength is possible and demonstrate the potentia

215 d from loss of white adipose tissue, reduced muscle strength, kyphosis, alopecia, hypothermia and sho

216 e intervention effects on physical function, muscle strength, lean mass (LM), fat mass (FM), bone min

217 y improve preoperative functional status and muscle strength levels in persons undergoing THA.

218 and passive range of motion (AROM and PROM), muscle strength, limb edema, and pain.

219 ts and to assess whether this change affects muscle strength loss.

220 ng balance (Functional Reach Test), skeletal muscle strength (manual muscle testing with dynamometry)

221 Drug efficacy was tested by measuring muscle strength manually (34 muscle groups) and quantita

222 , fatigue, erectile dysfunction, and reduced muscle strength/mass.

223 an occlusion maneuver to measure respiratory muscle strength (maximal change in airway pressure gener

224 To establish a functional in vitro assay for muscle strength, mdx murine myoblasts, the genetic homol

225 Aerobic capacity and muscle strength (measured in watts and newtons per kilog

226 The principal efficacy outcome was muscle strength, measured by quantitative dynomometry.

227 Voluntary muscle strength measurement has proven reliable in criti

228 A study was included if reliability of muscle strength measurements was determined in this popu

229 om a previously published report respiratory muscle strength measurements were available for 78 patie

230 functional testing did not reveal changes in muscle strength nor endurance in treated C3KO mice.

231 Maximal improvements in muscle strength occurred as early as 12 weeks after the

232 Quantitative muscle strength of knee extensor and the IBM functional

233 On the day of extubation, muscle strength of the four limbs, criteria for delirium

234 female mice, but has deleterious effects on muscle strength only in males.

235 o significant changes in several measures of muscle strength or exercise capacity with atorvastatin,

236 tatin for 6 months does not decrease average muscle strength or exercise performance in healthy, prev

237 rovements noted in exploratory end points of muscle strength or function, but the study was not power

238 urvival time without demonstrated effects on muscle strength or function, is the only approved treatm

239 ndurance-type exercise but has no effects on muscle strength or hypertrophy.

240 and 10 patients had either an improvement in muscle strength or maintained normal muscle strength.

241 ant effect of BK(2)R genotype on inspiratory muscle strength or on any variable in control subjects w

242 al working groups have proposed that loss of muscle strength or physical function should also be incl

243 via direct measurement (cognition, mobility, muscle strength) or self-report (vision, hearing).

244 e peak volume of oxygen consumed per minute, muscle strength, or insulin sensitivity.

245 nce intervals -13.943 to -3.015) decrease in muscle strength (P < 0.006).

246 OnTrack also resulted in better outcomes for muscle strength (P = .002) and physical fatigue (P < .00

247 comes were the rates of decline in isometric muscle strength, plasma phosphorylated axonal neurofilam

248 Exercise participation increased muscle strength preoperatively (18% in THA patients and

249 cardiorespiratory fitness (CRF, VO(2peak)), muscle strength (quadriceps peak torque), body compositi

250 ion reduces age-related deficits in skeletal muscle strength, quality, and mass, similar to ursolic a

251 ntly reduce age-related deficits in skeletal muscle strength, quality, and mass: ursolic acid (a pent

252 ant mice displayed myofiber necrosis, weaker muscle strength, reduced locomotion, and muscle-specific

253 ne showed reduced survival, body weight, and muscle strength, relative to untreated animals.

254 ram intervals, cardiac ejection fraction and muscle strength remained normal.

255 he enhanced muscle Ca(2+), force and in vivo muscle strength responses following isoproterenol stimul

256 and lower extremities measured by a 5-point muscle strength score and a 7-point Functional Independe

257 the modified Medical Research Council (MRC) muscle strength score for biceps and triceps in patients

258 total quantity, was associated with a higher muscle-strength score in both sexes throughout follow-up

259 rogate marker for the characteristic loss of muscle strength seen in this disease.

260 ss; secondary outcomes: changes in fat mass, muscle strength, sexual function, prostate volume, sebum

261 Changes in fat mass, muscle strength, sexual function, prostate volume, sebum

262 Examination of muscle strength showed reduced force generation in vivo

263 bone mineral content, cardiac function, and muscle strength significantly improved during rhGH treat

264 8%) and strong evidence to support improving muscle strength (SMD = 0.31; 95% CI: 0.12, 0.50; z = 3.2

265 overy of alpha-DG glycosylation and improved muscle strength, suggesting a systemic supply of FKRP pr

266 history, assessed by bi-monthly Quantitative Muscle Strength Testing and Medical Research Council str

267 Muscle involvement was assessed by MRI, muscle strength testing and muscle biopsy analysis.

268 CU-acquired weakness was diagnosed by manual muscle strength testing as soon as patients were awake a

269 ned by a mean of 14.9% based on Quantitative Muscle Strength Testing.

270 We further conducted muscle strength tests in humans, chimpanzees, and macaqu

271 henotype, muscle physiology, and (except for muscle strength tests) motor behaviors were all normal a

272 s are much more susceptible to a decrease in muscle strength than the diaphragm, and impairment of up

273 ion, are the cause of the severe decrease in muscle strength that characterizes these patients.

274 Vitamin D may improve muscle strength through a highly specific nuclear recept

275 gregates, decreases muscle fibrosis, reverts muscle strength to the level of healthy muscles and norm

276 mation of muscle fibrosis and stabilizes the muscle strength to the level of healthy muscles.

277 This group also increased muscle strength (total workload in RT exercises of upper

278 le ergometry can provide range of motion and muscle strength training for intensive care unit patient

279 e DM, and healthy children were assessed for muscle strength (using myometry) and function, and MRI T

280 Skeletal muscle strength, velocity, and power are markedly reduce

281 tment with carvedilol could enhance skeletal muscle strength via beta-arrestin-dependent pathways.

282 Celecoxib did not slow the decline in muscle strength, vital capacity, motor unit number estim

283 ts than the control condition in measures of muscle strength, walking speed, balance, and perceived h

284 Muscle strength was assessed at hospital discharge and a

285 Muscle strength was assessed by a hand grip test and the

286 Muscle strength was assessed during maximal voluntary is

287 the combination of low aerobic capacity and muscle strength was associated with a 3-fold risk for ty

288 An increase in muscle strength was detected in all treated animals and

289 Additionally, no atrophy was seen, muscle strength was generally preserved, and some patien

290 Muscle strength was measured with the British Medical Re

291 However, muscle strength was not improved and exercise intoleranc

292 Loss of muscle strength was progressive in homozygous D187N gels

293 opathological evaluation and measurements of muscle strength were accompanied by analyses of expressi

294 Low aerobic capacity and muscle strength were independently associated with incre

295 Changes in lean mass, muscle size, and muscle strength were similar between the groups.

296 r decline for direct measures of respiratory muscle strength, whereas VC showed little to no decline

297 e a number of ways for assessing objectively muscle strength, which can be categorized as techniques

298 ition with dual-energy X-ray absorptiometry, muscle strength with a handgrip dynamometer, and blood b

299 A decline of skeletal muscle strength with aging is a primary cause of mobilit

300 y comparing bilateral intrinsic hand and leg muscle strength with manual testing as well as manual de